Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Drug entities : Acer therapeutics inc. save search
Relief Therapeutics and Acer Therapeutics Announce that the European Commission Has Granted Orphan Drug Designation for ACER-001 in Maple Syrup Urine Disease
Published: 2022-08-12 (Crawled : 13:00) - biospace.com/
RLFTF | $1.45 0
|
n/a
|
| O: 5.71%
H: 2.7%
C: 0.0%
ACER | $0.9 -3.61% 420K
|
Health Technology
|
| O: 1.36%
H: 4.0%
C: -2.0%
acer-001 designation drug disease urine granted therapeutics
Acer Therapeutics and Relief Therapeutics Announce FDA Acceptance for Review of NDA Resubmission for ACER-001 for Treatment of UCDsPrescription Drug User Fee Act (PDUFA) target action date set for January 15, 2023
Published: 2022-07-28 (Crawled : 15:20) - biospace.com/
RLFTF | $1.45 0
|
n/a
|
| O: 3.08%
H: 0.0%
C: -6.79%
ACER | $0.9 -3.61% 420K
|
Health Technology
|
| O: 0.7%
H: 4.86%
C: -1.39%
acer-001 treatment fda drug set resubmission therapeutics review
Acer Therapeutics Announces Resubmission of New Drug Application for ACER-001 for Treatment of UCDs
Published: 2022-07-18 (Crawled : 13:20) - biospace.com/
ACER | $0.9 -3.61% 420K
|
Health Technology
|
| O: 4.3%
H: 1.87%
C: 0.0%
acer-001 treatment drug application resubmission therapeutics
Acer Therapeutics and Relief Therapeutics Announce Update on U.S. FDA Review of New Drug Application (NDA) for ACER-001
Published: 2022-06-21 (Crawled : 16:00) - biospace.com/
RLFTF | $1.45 0
|
n/a
|
| O: -21.33%
H: 27.12%
C: 14.41%
RLFTY | $1.4006 733.33% 100
|
n/a
|
| O: -15.91%
H: 8.65%
C: 8.65%
ACER | $0.9 -3.61% 420K
|
Health Technology
|
| O: -10.23%
H: 0.0%
C: 0.0%
acer-001 fda drug application therapeutics review update
Acer Therapeutics and Relief Therapeutics Announce FDA Acceptance for Filing of New Drug Application for ACER-001 to Treat Urea Cycle DisordersFDA sets PDUFA target action date of June 5, 2022
Published: 2021-10-06 (Crawled : 14:00) - biospace.com/
ACER | $0.9 -3.61% 420K
|
Health Technology
|
| O: 12.45%
H: 8.57%
C: 3.57%
urea new drug fda fda acceptance pdufa drug
Acer Therapeutics and Relief Therapeutics Announce FDA Acceptance for Filing of New Drug Application for ACER-001 to Treat Urea Cycle Disorders
Published: 2021-10-06 (Crawled : 13:00) - acertx.com
ACER | $0.9 -3.61% 420K
|
Health Technology
|
| O: 12.45%
H: 8.57%
C: 3.57%
urea new drug fda fda acceptance drug
Acer Therapeutics and Relief Therapeutics Announce Submission of a New Drug Application to the U.S. FDA for ACER-001 for Treatment of Urea Cycle Disorders
Published: 2021-08-09 (Crawled : 13:00) - globenewswire.com
ACER | $0.9 -3.61% 420K
|
Health Technology
|
| O: 2.83%
H: 4.33%
C: 3.54%
urea new drug treatment fda drug submission
RELIEF THERAPEUTICS Holdings AG: Acer Therapeutics and Relief Therapeutics Announce Submission of a New Drug Application to the U.S. FDA for ACER-001 for Treatment of Urea Cycle Disorders
Published: 2021-08-09 (Crawled : 07:00) - biospace.com/
ACER | $0.9 -3.61% 420K
|
Health Technology
|
| O: 2.83%
H: 4.33%
C: 3.54%
urea new drug treatment fda drug submission
Gainers vs Losers
| 46% | 54% |
Top 10 Gainers
SGBX | $0.26 80.43% 54M
|
Producer Manufacturing
LICN | $1.0 78.57% 3.3M
|
CSSE 4 | $0.2656 74.39% 9.7M
|
Consumer Services
BRFH 4 | $1.89 71.82% 32M
|
Manufacturing
ACON | $0.49 70.14% 24M
|
n/a
BOF | $1.95 66.67% 920K
|
MTC | $3.62 61.61% 790K
|
Technology Services
AMST | $3.22 61.0% 720K
|
Technology Services
PCSA | $2.28 40.74% 37M
|
Producer Manufacturing
EVA | $0.626 39.14% 2.3M
|
Process Industries
Your saved searches
Save your searches and get alerts when important news are released.